Canaccord analyst David Hynes lowered the firm’s price target on ZoomInfo to $21 from $26 and keeps a Buy rating on the shares. The firm said bad on the positive side, Q3 revenue and operating margins came in slightly above the high-end of guidance, and management reiterated its full-year targets for revenue and cash flow but the story is, in Canaccord’s view, “catalyst light” for several more quarters.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on ZI: